Pharmacy Times: Hierarchy of breast cancer cells
UC research pinpoints hierarchy of breast cancer cells as potential cause for treatment resistance
It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent University of Cincinnati research published in the journal eLife.
The findings demonstrated the importance of accounting for specific cell states present in a tumor in order to determine the appropriate combination of drugs necessary to eliminate all the cell states present and halt treatment resistance. The study was led by author Syn Yeo, PhD, research instructor in the department of cancer biology.
Syn Yeo, PhD, research instructor in the department of cancer biology at the UC College of Medicine. Photo by UC Creative + Brand.
He and other researchers noted that the variation between cell states may cause difficulties during treatment if differences in cell states are not accounted for.
"This diversity poses a problem to treating patients because particular subsets of tumor cells may be drug resistant and eventually lead to disease recurrence," says Yeo. "One of the factors contributing to this diversity is the fact that tumor cells can exist in different cellular states, ranging from more stem-like cells that can become other cell types to more differentiated cells that have been coded to serve a purpose, or do a certain 'job' within the system.”
Read the full Pharmacy Times story.
Featured photo of breast cancer cells courtesy of the National Cancer Institute.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
The future, decoded. UC scholars reveal what’s next
May 20, 2026
The University of Cincinnati’s NEXT Innovation Scholars presented Gen Z-fueled insights on possible future trends at the Futures Forum 2026. Here’s what they see ahead.
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.